Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer

Christine L Hann, Vincent C Daniel, Elizabeth A Sugar, Irina Dobromilskaya, Sara C Murphy, Leslie Cope, Xue Lin, Jared S Hierman, Daniel L Wilburn, David Neil Watkins, Charles M Rudin

Research output: Contribution to journalArticleResearchpeer-review

154 Citations (Scopus)
Original languageEnglish
Pages (from-to)2321 - 2328
Number of pages8
JournalCancer Research
Volume68
Issue number7
Publication statusPublished - 2008
Externally publishedYes

Cite this

Hann, C. L., Daniel, V. C., Sugar, E. A., Dobromilskaya, I., Murphy, S. C., Cope, L., ... Rudin, C. M. (2008). Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Research, 68(7), 2321 - 2328.
Hann, Christine L ; Daniel, Vincent C ; Sugar, Elizabeth A ; Dobromilskaya, Irina ; Murphy, Sara C ; Cope, Leslie ; Lin, Xue ; Hierman, Jared S ; Wilburn, Daniel L ; Watkins, David Neil ; Rudin, Charles M. / Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. In: Cancer Research. 2008 ; Vol. 68, No. 7. pp. 2321 - 2328.
@article{6c7e22420aa64e7f82f9259f3e64a125,
title = "Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer",
author = "Hann, {Christine L} and Daniel, {Vincent C} and Sugar, {Elizabeth A} and Irina Dobromilskaya and Murphy, {Sara C} and Leslie Cope and Xue Lin and Hierman, {Jared S} and Wilburn, {Daniel L} and Watkins, {David Neil} and Rudin, {Charles M}",
year = "2008",
language = "English",
volume = "68",
pages = "2321 -- 2328",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research (AACR)",
number = "7",

}

Hann, CL, Daniel, VC, Sugar, EA, Dobromilskaya, I, Murphy, SC, Cope, L, Lin, X, Hierman, JS, Wilburn, DL, Watkins, DN & Rudin, CM 2008, 'Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer', Cancer Research, vol. 68, no. 7, pp. 2321 - 2328.

Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. / Hann, Christine L; Daniel, Vincent C; Sugar, Elizabeth A; Dobromilskaya, Irina; Murphy, Sara C; Cope, Leslie; Lin, Xue; Hierman, Jared S; Wilburn, Daniel L; Watkins, David Neil; Rudin, Charles M.

In: Cancer Research, Vol. 68, No. 7, 2008, p. 2321 - 2328.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer

AU - Hann, Christine L

AU - Daniel, Vincent C

AU - Sugar, Elizabeth A

AU - Dobromilskaya, Irina

AU - Murphy, Sara C

AU - Cope, Leslie

AU - Lin, Xue

AU - Hierman, Jared S

AU - Wilburn, Daniel L

AU - Watkins, David Neil

AU - Rudin, Charles M

PY - 2008

Y1 - 2008

UR - http://cancerres.aacrjournals.org/cgi/reprint/68/7/2321

M3 - Article

VL - 68

SP - 2321

EP - 2328

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 7

ER -

Hann CL, Daniel VC, Sugar EA, Dobromilskaya I, Murphy SC, Cope L et al. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Research. 2008;68(7):2321 - 2328.